|
"劉俊人"的相關文件
顯示項目 76-125 / 295 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2015 |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages
|
Liu, Chun-Jen; Chen, Ting-Chih; Chen, Pei-Jer; Wang, Hurng-Yi; Tseng, Tai-Chung; Cheng, Huei-Ru; Liu, Chen-Hua; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 王弘毅 |
| 國立臺灣大學 |
2015 |
Development of risk scoring system for stratifying population for hepatocellular carcinoma screening
|
Hung, Yi-Chun; Lin, Chih-Lin; Liu, Chun-Jen; Hung, Hung; Lin, Shi-Ming; Lee, Shou-Dong; Chen, Pei-Jer; Chuang, Shu-Chun; Yu, Ming-Whei; 洪弘; 于明暉; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung; 徐士哲; 劉俊人 |
| 國立臺灣大學 |
2015 |
Increasing obesity and GI diseases in ASIA: Gut and Obesity in Asia (GOASIA) consensus statements on obesity and gastrointestinal diseases
|
Calvin, Koh Jianyi; Mun, Loo Wai; Kheong, Chan Wah; Yanphilip, Chiu Wai; Myung-Gyuchoi; Lee, Goh Khean; Gonlachanvit, Sutep; Yeh, Lee Yong; Lesmana, Laurentius A.; Li, You-Ming; Jen, Liu Chun; Matsuura, Bunzo; Nakajima, Atsushi; Sollano, Jose D.; Sugano, Kentaro; Wong, Vincent W. S.; Yu, Hokhek; Young, Danyock; 劉俊人 |
| 國立臺灣大學 |
2015 |
Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients
|
Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Wu, Hui-Lin; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Long-term Effectiveness of Entecavir among Hepatitis B Patients in Taiwan
|
Yeh, Yi-Chun; Liu, Chun-Jen; Chen, Pei-Jer; Lai, Mei-Shu; 賴美淑; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
|
Lin, Chih-Lin; Liu, Chen-Hua; Wang, Chia-Chi; Liang, Cheng-Chao; Su, Tung-Hung; Liu, Chun-Jen; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2015 |
The NIACE score helps predict the survival of Asian hepatocellular carcinoma patients
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Adhoute, Xavier; Bourliere, Marc; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Jeng, Yung-Ming; Cheng, Huei-Ru; Liu, Chen-Hua; Tseng, Tai-Chung; Ling, Thai-Yen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 林泰元; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2014 |
THE CRISPR/Cas9 SYSTEM FACILITATES ELIMINATION OF THE PERSISTENT INTRAHEPATIC HBV GENOMES IN VIVO
|
Yang, H. -C.; Lin, S. -R.; Liu, C. -J.; Kao, J. -H.; Chen, D. -S.; Chen, P. -J.; 陳定信; 高嘉宏; 楊宏志; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
|
Lin, Su-Ru; Yang, Hung-Chih; Kuo, Yi-Ting; Liu, Chun-Jen; Yang, Ta-Yu; Sung, Ku-Chun; Lin, You-Yu; Wang, Hurng-Yi; Wang, Chih-Chiang; Shen, Yueh-Chi; Wu, Fang-Yi; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; 陳定信; 高嘉宏; 楊宏志; 劉俊人; 陳培哲; 王弘毅 |
| 國立臺灣大學 |
2014 |
Identification of a Liver Cirrhosis Signature in Plasma for Predicting Hepatocellular Carcinoma Risk in a Population-Based Cohort of Hepatitis B Carriers
|
Liu, Chia-Chi; Wang, Ya-Hui; Chuang, Eric Y.; Tsai, Mong-Hsun; Chuang, Ya-Hui; Lin, Chih-Lin; Liu, Chun-Jen; Hsiao, Bo-Yu; Lin, Shi-Ming; Liu, Li-Yu; Yu, Ming-Whei; 于明暉; 莊雅惠; 劉俊人 |
| 國立臺灣大學 |
2014 |
Treatment of patients with dual hepatitis C and B by peginterferon alpha and ribavirin reduced risk of hepatocellular carcinoma and mortality
|
Liu, Chun-Jen; Chu, Yu-Tseng; Shau, Wen-Yi; Kuo, Raymond N.; Chen, Pei-Jer; Lai, Mei-Shu; 賴美淑; 劉俊人; 郭年真; 陳培哲 |
| 國立臺灣大學 |
2014 |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Chen, Ting-Chih; Tseng, Tai-Chung; Liu, Chen-Hua; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 吳慧琳; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
|
Su, Tung-Hung; Kao, Jia-Horng; Liu, Chun-Jen; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2014 |
Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study
|
Yeh, Yi-Chun; Liu, Chun-Jen; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Shau, Wen-Yi; Chen, Pei-Jer; Lai, Mei-Shu; 賴美淑; 劉俊人; 郭年真; 陳培哲 |
| 國立臺灣大學 |
2014 |
Clinical presentations of patients from different age cohorts with biliary tract stone diseases
|
Hu, Kuang-Chun; Wang, Horng-Yuan; Chang, Wen-Hsiung; Chu, Cheng-Hsin; Lin, Shee-Chan; Liu, Chun-Jen; Wu, Ming-Shiang; Shih, Shou-Chuan; 劉俊人; 吳明賢 |
| 國立臺灣大學 |
2014 |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu, Hui-Lin; Kao, Jia-Horng; Chen, Ting-Chih; Wu, Wen-Hsuan; Liu, Chen-Hua; Su, Tung-Hung; Yang, Hung-Chih; Chen, Ding-Shinn; Chen, Pei-Jer; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin
|
Chen, Ming-Yao; Liu, Chen-Hua; Chen, Ting-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Liu, Chun-Jen; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues
|
Liu, Chun-Jen; 劉俊人 |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立臺灣大學 |
2014 |
A ten-year follow-up of patients with dual chronic hepatitis B and C virus infections: Outcomes and determinants
|
Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals
|
Wong, V. W. -S.; Liu, C. -J.; 劉俊人 |
| 國立臺灣大學 |
2014 |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Chen, Chi-Ling; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2014 |
Plasma Adipokines and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus-Infected Carriers: A Prospective Study in Taiwan
|
Chen, Chi-Ling; Yang, Wei-Shiung; Yang, Hwai-I; Chen, Chuen-Fei; You, San-Lin; Wang, Li-Yu; Lu, Sheng-Nan; Liu, Chun-Jen; Kao, Jia-Horng; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Chien-Jen; 陳定信; 陳建仁; 高嘉宏; 劉俊人; 楊偉勛; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2014 |
Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease
|
Hu, Kuang-Chun; Wang, Horng-Yuan; Liu, Sung-Chen; Liu, Chuan-Chuan; Hung, Chung-Lieh; Bair, Ming-Jong; Liu, Chun-Jen; Wu, Ming-Shiang; Shih, Shou-Chuan; 劉俊人; 吳明賢 |
| 國立臺灣大學 |
2014 |
Patients with chronic hepatitis C virus infection have an increased risk of non-Hodgkin's lymphoma
|
Su, Tung-Hung; Liu, Chun-Jen; Chen, Chi-Ling; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2014 |
Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries
|
Dan, Yock Young; Wong, John B.; Hamid, Saeed S.; Han, Kwang-Hyub; Jia, Ji Dong; Liu, Chun-Jen; Piratvisuth, Teerha; Lok, Anna S. F.; Lim, Seng Gee; 劉俊人 |
| 國立臺灣大學 |
2014 |
Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma
|
Cheng, Hsiang-Yun; Kang, Pei-Jen; Chuang, Ya-Hui; Wang, Ya-Hui; Jan, Meng-Chin; Wu, Chih-Feng; Lin, Chih-Lin; Liu, Chun-Jen; Liaw, Yun-Fan; Lin, Shi-Ming; Chen, Pei-Jer; Lee, Shou-Dong; Yu, Ming-Whei; 于明暉; 莊雅惠; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Chen, Chi-Ling; Hsu, Cheng-An; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Milder clinical manifestation of scrub typhus in Kinmen, Taiwan
|
Su, Tung-Hung; Liu, Chun-Jen; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2013 |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su, Tung-Hung; Liu, Chen-Hua; Liu, Chun-Jen; Chen, Chi-Ling; Ting, Te-Tien; Tseng, Tai-Chung; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Chen, Hung-Chia; Liu, Chen-Hua; Jeng, Jenher; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 徐士哲; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Chi-Ling; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression
|
Huang, Chi-Jung; Wu, Chih-Feng; Lan, Chia-Ying; Sung, Feng-Yu; Lin, Chih-Lin; Liu, Chun-Jen; Liu, Hsin-Fu; Yu, Ming-Whei; 于明暉; 劉俊人 |
| 國立臺灣大學 |
2013 |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
|
Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Lu, Sheng-Nan; Liu, Chen-Hua; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Su, Wei-Wen; Lin, Chih-Lin; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT
|
Liu, C. -J.; Wang, C. -C.; Yang, S. -S.; Su, C. -W.; Liao, L. -Y.; Lee, T. -H.; Chuang, W. -L.; Chen, C. -L.; Chien, R. -N.; Peng, C. -Y.; Lee, C. -M.; Lee, Y. -F.; Kao, J. -H.; Chen, P. -J.; Chen, D. -S.; 劉俊人 |
| 國立臺灣大學 |
2013 |
Global Perspective on the Natural History of Chronic Hepatitis B: Role of Hepatitis B Virus Genotypes A to J
|
Liu, Chun-Jen; Kao, Jia-Horng; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2013 |
A PROSPECTIVE COHORT STUDY OF MULTIPLE RISK FACTORS AND AGE AT ONSET OF HEPATOCELLULAR CARCINOMA IN HEPATITIS B VIRUS CARRIERS
|
Hung, Y. -C.; Lin, C. -L.; Liu, C. -J.; Chen, C. -J.; Liaw, Y. -F.; Chang, H. -C.; Lin, S. -M.; Lee, S. -D.; Chen, P. -J.; Yu, M. -W.; 陳建仁; 于明暉; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
|
Cheng, Huei-Ru; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hwai-I; Chen, Chien-Jen; Kao, Jia-Horng; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2013 |
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study
|
Dai, Chia-Yen; Tseng, Tai-Chung; Wong, Grace Lai Hung; Huang, Jee-Fu; Wong, Vincent Wai Sun; Liu, Chun-Jen; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Chan, Henry Lik Yuen; Chen, Ding-Shinn; 陳定信; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2013 |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
|
Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Risk Stratification of Hepatocellular Carcinoma in Hepatitis B Virus e Antigen-Negative Carriers by Combining Viral Biomarkers
|
Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Chi-Ling; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Yang, Wan-Ting; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
|
Yuan, Quan; Song, Liu-Wei; Liu, Chun-Jen; Li, Zhuo; Liu, Ping-Guo; Huang, Cheng-Hao; Yan, Yan; Ge, Sheng-Xiang; Wang, Ying-Bin; Peng, Cheng-Yuan; Zhang, Jun; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; Xia, Ning-Shao; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Comparative Effectiveness of Interferon and Pegylated Interferon against Chronic Hepatitis B in Taiwan
|
Liu, Chun-Jen; Yeh, Yi-Chun; Kau, Raymond N. C.; Lai, Chiu-Ling; Yang, Yen-Yun; Lai, Mei-Shu; Chen, Pei-Jer; 賴美淑; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Pegylated Interferon-alpha 2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2013 |
A Phase I/IIa study of safety, tolerability, and pharma-cokinetic profiles of TG-2349, a pan-genotypic HCV protease inhibitor, in healthy East Asian and Caucasian subjects, and its antiviral activity in chronic hepatitis C patients
|
Tsai, Chen-En; Chang, Li-Wen; Chang, Yu-Ting; Hsu, Chiung-Yuan; Chen, Chih-Ming; Tsai, Cheng-Yuan; Lin, Chu-Chung; King, Chi-Hsin R.; Liu, Chun-Jen; Chen, Ding-Shinn; Hsu, Ming-Chu; 陳定信; 劉俊人 |
顯示項目 76-125 / 295 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
